Attendance is free but space is limited and registration is required. Register now.

September 15, 2017
Huntsman Cancer Institute at the University of Utah 
2000 Circle of Hope, Salt Lake City
Time Event Speaker
8:30 a.m. Welcome & Introductions

Mary Beckerle, PhD
CEO and Director, Huntsman Cancer Institute

8:40 a.m. Metabolic Mechanisms of Cancer Initiation and Progression

Sean Morrison, PhD
Director, Children’s Medical Center Research Institute
Professor and Chair, Pediatric Genetics
UT Southwestern Medical Center
Investigator, Howard Hughes Medical Institute

9:20 a.m. Progress and Challenges in Germline Genetic Testing

Judy Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School

10:00 a.m. Coffee Break
10:20 a.m. Somatic p53 Mutations Drive Development of Triple-Negative Breast Cancer with Evolutionarily Distinct Metastases

Guillermina (Gigi) Lozano, PhD
Professor and Chair, Department of Genetics
The University of Texas MD Anderson Cancer Center

11:00 a.m. Targeting Inflammation and Cancer: A Double-Edged Sword

Raymond DuBois, MD, PhD
Investigator, Hollings Cancer Center
Dean of the College of Medicine, Medical University of South Carolina

11:40 a.m. Molecular Pathways in Pediatric Medulloblastoma

Martine Roussel, PhD
Endowed Chair of Molecular Oncology
St. Jude Children’s Research Hospital
Professor, Department of Molecular Sciences
University of Tennessee, Memphis

12:20 p.m. Lunch Break
1:30 p.m. Understanding Metabolic Phenotypes and Liabilities in Human Cancer

Ralph Deberardinis, MD, PhD 

Chief, Division of Pediatric Genetics and Metabolism
Children’s Medical Center Research Institute
Associate Professor, Department of Pediatrics and Genetics
UT Southwestern Medical Center

2:10 p.m. The Moonshot and Beyond: NCI Priorities for Cancer Control Research

Robert Croyle, PhD
Director, Division of Cancer Control and Population Sciences
National Cancer Institute

2:50 p.m. Coffee Break
3:20 p.m. Response and Resistance to PD-1 Blockade

Antoni Ribas, MD, PhD
Director, Tumor Immunology Program
Jonsson Comprehensive Cancer Center
Professor, Departments of Medicine, Surgery, and Molecular and Medical Pharmacology
University of California, Los Angeles

4:00 p.m. Closing Remarks

Mary Beckerle, PhD
CEO and Director, Huntsman Cancer Institute

Scientific Poster Session